Document is current
Any future updates will be listed below
-
Authors
Cui, Chuanliang
Chen, Yu
Luo, Zhiguo
Zou, Zhengyun
Jiang, Yu
Pan, Hongming
Fan, Qingxia
Zhao, Jianfu
Xu, Qing
Jiang, Renbing
Wang, Xuan
Ma, Taiyang
Guo, Zhen
Si, Lu
Chi, Zhihong
Sheng, Xinan
Dou, Yiwei
Tan, Qian
- License Information
-
More Information
Article History
Received: 20 July 2022
Accepted: 21 December 2022
First Online: 6 February 2023
Declarations
:
: The study was approved by The Ethics Committees of Beijing Cancer Hospital and done in accordance with the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guidelines. All patients provided written informed consent before study entry.
: All patients have provided written informed consent for publication.
: Taiyang Ma, Yiwei Dou and Qian Tan are employees of Taizhou Hanzhong Biomedical Co., Ltd. (A member of Lepu Biopharma Co., Ltd.). All the other authors have declared no conflicts of interest.
